(Q44647470)

5 December 2017

Immunological effects of cefodizime in patients undergoing antineoplastic chemotherapy (English)

1 reference

5 December 2017

1 reference

P Mallmann

1

1 reference

PubMed ID

1526683

5 December 2017

P Brühl

series ordinal

2

1 reference

5 December 2017

1 January 1992

1 reference

5 December 2017

1 reference

5 December 2017

20 Suppl 1

1 reference

5 December 2017

S67-70

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01709958

5 December 2017

0 references

cites work

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01709958

Toward a chronoimmunomodulation by cefodizime in multiple myeloma and chronic uremia

21 January 2018

1 reference

12 December 2020

Chemotherapy of disseminated testicular cancer a random prospective study

1 reference

12 December 2020

Combination chemotherapy in germinal cell tumors

1 reference

12 December 2020

Cefodizime: a new cephalosporin with apparent immune-stimulating properties in chronic renal failure.

1 reference

12 December 2020

Cefodizime, an aminothiazolyl cephalosporin. IV. Influence on the immune system

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01709958

1 reference

5 December 2017

1 reference

PubMed ID

1526683